del Val M - Search Results

1

A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection.

Jonjić S, del Val M, Keil GM, Reddehase MJ, Koszinowski UH. Jonjić S, et al. Among authors: del val m. J Virol. 1988 May;62(5):1653-8. doi: 10.1128/JVI.62.5.1653-1658.1988. J Virol. 1988. PMID: 2833615 Free PMC article.

2

Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope.

Del Val M, Schlicht HJ, Volkmer H, Messerle M, Reddehase MJ, Koszinowski UH. Del Val M, et al. J Virol. 1991 Jul;65(7):3641-6. doi: 10.1128/JVI.65.7.3641-3646.1991. J Virol. 1991. PMID: 1710286 Free PMC article.

3

Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89.

Del Val M, Volkmer H, Rothbard JB, Jonjić S, Messerle M, Schickedanz J, Reddehase MJ, Koszinowski UH. Del Val M, et al. J Virol. 1988 Nov;62(11):3965-72. doi: 10.1128/JVI.62.11.3965-3972.1988. J Virol. 1988. PMID: 2459408 Free PMC article.

4

Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase.

Del Val M, Münch K, Reddehase MJ, Koszinowski UH. Del Val M, et al. Cell. 1989 Jul 28;58(2):305-15. doi: 10.1016/0092-8674(89)90845-3. Cell. 1989. PMID: 2473842 Free article.

5

Principles of cytomegalovirus antigen presentation in vitro and in vivo.

Koszinowski UH, Reddehase MJ, Del Val M. Koszinowski UH, et al. Among authors: del val m. Semin Immunol. 1992 Apr;4(2):71-9. Semin Immunol. 1992. PMID: 1319768 Review.

6

Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment.

del Val M, Hengel H, Häcker H, Hartlaub U, Ruppert T, Lucin P, Koszinowski UH. del Val M, et al. J Exp Med. 1992 Sep 1;176(3):729-38. doi: 10.1084/jem.176.3.729. J Exp Med. 1992. PMID: 1324970 Free PMC article.

Characterization of endogenous antigenic peptides identified the pp89 peptide as the nonapeptide 168YPHFMPTNL176 (del Val, M., H.-J. Schlicht, T. Ruppert, M.J. Reddehase, and U.H. ...Subsequent expression of MCMV early genes prevents presentation of pp …

Characterization of endogenous antigenic peptides identified the pp89 peptide as the nonapeptide 168YPHFMPTNL176 (del Val, …

7

Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.

Del Val M, Schlicht HJ, Ruppert T, Reddehase MJ, Koszinowski UH. Del Val M, et al. Cell. 1991 Sep 20;66(6):1145-53. doi: 10.1016/0092-8674(91)90037-y. Cell. 1991. PMID: 1913805 Free article.

8

Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes.

Koszinowski UH, Reddehase MJ, Keil GM, Volkmer H, Jonjic S, Messerle M, del Val M, Mutter W, Münch K, Bühler B. Koszinowski UH, et al. Among authors: del val m. Immunol Lett. 1987 Dec;16(3-4):185-92. doi: 10.1016/0165-2478(87)90146-5. Immunol Lett. 1987. PMID: 2832318 Review.

9

Cellular and molecular basis of the protective immune response to cytomegalovirus infection.

Koszinowski UH, Del Val M, Reddehase MJ. Koszinowski UH, et al. Among authors: del val m. Curr Top Microbiol Immunol. 1990;154:189-220. doi: 10.1007/978-3-642-74980-3_8. Curr Top Microbiol Immunol. 1990. PMID: 1693327 Review. No abstract available.

10

HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope.

López D, Samino Y, Koszinowski UH, Del Val M. López D, et al. Among authors: del val m. J Immunol. 2001 Oct 15;167(8):4238-44. doi: 10.4049/jimmunol.167.8.4238. J Immunol. 2001. PMID: 11591745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page